This one-day virtual event from the NCRI aims to address current and future challenges in the identification and development of innovative drugs for cancer treatment. Delegates will hear from eminent speakers to learn more about what we need to know and do now in order to prepare for the future, how we can work together to achieve greater innovation and impact and the case for change in certain areas of research.
This webinar from our Regional & Affinity Group series is brought to you by the BSI Immunometabolism Affinity Group. Professor Hal Drakesmith (University of Oxford) will present his research group's work showing that a lack of iron can inhibit adaptive immune responses.
Our Corporate Member Fluidigm are delighted to welcome Dr Bernd Bodenmiller from the Bodenmiller Lab in Zurich to discuss the application of Imaging Mass Cytometry™, among other technologies, to in-depth tumour profiling in order to support clinical decision-making.
The next event from the Francis Crick Institute's 'Medicine at the Crick' series, 'The new medicine of DNA repair pathways: damage repair vulnerabilities in cancer', will take place virtually on 11 February 2021 from 14:00-17:20 GMT.